Wednesday, February 19, 2020 1:04:52 AM
Learningcurve2020, Even you have to admit that 'something' positive IS about to happen. Although this is not guaranteed, it is most probable. Do you think the ASM meeting will be positive for the company?
It makes no sense (and it is inconsistent with the way NWBO has announced the ASM meeting for the last 4 years) that NWBO give a 60-day preannouncement of an event, promising something 'interesting' only to present the same old data. Whatever they are planning to present will, in worst case, place NWBO in a more positive light and in, the best case, will permanently destroy the idea that the trial failed or will fail.
Your comment, reverse-mergers 'never work out', is true when evaluating them in regards to penny stock companies. But IMHO when you factor in a company with a cancer vaccine that becomes the new SOC for GBM (and potentially all other cancers), I am sure you will agree that it will work.
By the way, I just listed a few ideas that, at this point, is total speculation. There are many more that I did not mention such as a merger, BP partnership with upfront funding, buyout, etc. Though I could be wrong, there is something that is going on that NWBO requires a shareholder vote but does not want to make public yet.
I think the meeting will indeed be 'interesting'.
It makes no sense (and it is inconsistent with the way NWBO has announced the ASM meeting for the last 4 years) that NWBO give a 60-day preannouncement of an event, promising something 'interesting' only to present the same old data. Whatever they are planning to present will, in worst case, place NWBO in a more positive light and in, the best case, will permanently destroy the idea that the trial failed or will fail.
Your comment, reverse-mergers 'never work out', is true when evaluating them in regards to penny stock companies. But IMHO when you factor in a company with a cancer vaccine that becomes the new SOC for GBM (and potentially all other cancers), I am sure you will agree that it will work.
By the way, I just listed a few ideas that, at this point, is total speculation. There are many more that I did not mention such as a merger, BP partnership with upfront funding, buyout, etc. Though I could be wrong, there is something that is going on that NWBO requires a shareholder vote but does not want to make public yet.
I think the meeting will indeed be 'interesting'.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM

